Nuclear factor erythroid 2-related factor 2 (Nrf2) is involved in tumor drug resistance, but its role in imatinib resistance of chronic myeloid leukemia (CML) remains elusive. The gene discussed is NFE2L2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.